Peripheral neuropathies are characterized by nerves damage and axonal loss, and they
could be classified in hereditary or acquired forms. Acquired peripheral neuropathies are …

An overview of the cannabinoid type 2 receptor system and it... : Current Opinion in
Anesthesiology An overview of the cannabinoid type 2 receptor system and its therapeutic …

Background Neuropathy is a debilitating toxicity associated with various chemotherapy
agents. We evaluated the association between common comorbid conditions and the …

A ruthenium (II)‐catalyzed asymmetric intramolecular hydroarylation assisted by a chiral
transient directing group has been developed. A series of 2, 3‐dihydrobenzofurans bearing …

Background Mixed cannabinoid receptor 1 and 2 (CB 1 and CB 2) agonists such as Δ 9-
tetrahydrocannabinol (Δ 9-THC) can produce tolerance, physical withdrawal, and unwanted …

Cannabinoid type 2 (CB2) agonists are neuroprotective and appear to play modulatory roles
in neurodegenerative processes in Alzheimer's disease. We have studied the effect of 1-((3 …

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious and often persistent
adverse consequence of certain chemotherapeutic agents. It is a major dose-limiting factor …

The endocannabinoid system (ECS) comprises two cognate endocannabinoid receptors
referred to as CB1R and CB2R. ECS dysregulation is apparent in neurodegenerative/neuro …

Chronic pain is a complex sensory, cognitive, and emotional experience that imposes a
great personal, psychological, and socioeconomic burden on patients. An estimated 1.5 …

Painful peripheral neuropathy is a dose-limiting side effect of paclitaxel therapy, which
hampers the optimal clinical management of chemotherapy in cancer patients. Currently the …